Accelerate Diagnostics

360Dx Top 30 Drops 5 Percent in June

360Dx Top 30 Inches Up in May After April Plummet

Accelerate Diagnostics Q1 Revenues Climb 20 Percent

Accelerate Diagnostics Registers Microbial ID Sample Prep, Blood Culture Kit With FDA

360Dx Top 30 Falls Slightly in March

In Brief This Week: Castle Biosciences, Roche, Biocept, Ellume, Accelerate Diagnostics, and More

Accelerate Diagnostics Q4 Revenues Rise 6 Percent

360Dx Top 30 Plummets 17 Percent in January

Accelerate Diagnostics CEO Lays Out Plans at JP Morgan Healthcare Conference

Accelerate Diagnostics Q3 Revenues Decline 14 Percent, Miss Analyst Revenue Estimate

360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August

Accelerate Diagnostics Q2 Revenues Rise 33 Percent, Miss Analyst Estimates

Accelerate Diagnostics Nabs CE Mark for New Configuration of Antimicrobial Susceptibility Test Kit